|
NUP37 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64390723256247E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.99804666939963E-12 |
| Normal-vs-Stage2 |
1.88850000004681E-06 |
| Normal-vs-Stage3 |
8.3366646919103E-13 |
| Normal-vs-Stage4 |
1.62581059726108E-12 |
| Stage1-vs-Stage2 |
7.083800E-01 |
| Stage1-vs-Stage3 |
1.527420E-01 |
| Stage1-vs-Stage4 |
6.837100E-04 |
| Stage2-vs-Stage3 |
5.369800E-01 |
| Stage2-vs-Stage4 |
5.542400E-02 |
| Stage3-vs-Stage4 |
6.729500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.86284321301855E-12 |
| Normal-vs-AfricanAmerican |
1.53320000029211E-08 |
| Normal-vs-Asian |
8.20320000038954E-07 |
| Caucasian-vs-AfricanAmerican |
3.116000E-01 |
| Caucasian-vs-Asian |
4.707400E-01 |
| AfricanAmerican-vs-Asian |
1.346600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63169477929159E-12 |
| Normal-vs-Female |
1.98763228098642E-12 |
| Male-vs-Female |
1.019620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.27510224601224E-11 |
| Normal-vs-Age(41-60Yrs) |
4.10427247743428E-12 |
| Normal-vs-Age(61-80Yrs) |
1.65667479734566E-12 |
| Normal-vs-Age(81-100Yrs) |
4.598900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.013200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.302300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.894400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.370780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.565200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.710200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.395800E-02 |
| Classical-VS-Follicular |
6.372400E-02 |
| Classical-VS-Other |
2.277800E-01 |
| Classical-VS-Normal |
7.33139993158716E-10 |
| Tall-VS-Follicular |
8.745800E-01 |
| Tall-VS-Other |
7.944400E-01 |
| Tall-VS-Normal |
5.76609981983722E-10 |
| Follicular-VS-Other |
8.096000E-01 |
| Follicular-VS-Normal |
1.13260001377569E-09 |
| Other-VS-Normal |
1.571860E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92235116713846E-12 |
| Normal-vs-N1 |
2.18391971174015E-12 |
| N0-vs-N1 |
8.380000E-02 |
|
|
